![Eric Hyllengren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hyllengren
Finanzdirektor/CFO bei
TENAYA THERAPEUTICS, INC.
Vermögen: 202 243 $ am 30.06.2026
Profil
Mr. Eric Hyllengren is a Chief Financial & Accounting Officer at Tenaya Therapeutics, Inc. Mr. Hyllengren was previously employed as a Chief Financial & Accounting Officer by Zura Bio Ltd., a Chief Financial, Operating & Accounting Officer by Atara Biotherapeutics, Inc., and an Executive Director-Business Development by Amgen, Inc. He received his undergraduate degree from the University of Notre Dame and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 17.617 ( 0,2 % ) | 202 243 $ | 30.06.2026 |
Aktive Positionen von Eric Hyllengren
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Finanzdirektor/CFO | 13.07.2026 |
Ehemalige bekannte Positionen von Eric Hyllengren
| Unternehmen | Position | Ende |
|---|---|---|
| ZURA BIO LIMITED | Finanzdirektor/CFO | 20.04.2026 |
| ATARA BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 31.03.2025 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Eric Hyllengren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
